Leber Congenital Amaurosis (LCA)

Sponsored diagnostic testing programs for Leber Congenital Amaurosis (LCA)

Leber congenital amaurosis is an early-onset retinal dystrophy causing severe visual impairment or blindness in infancy. Symptoms include nystagmus, poor pupillary responses, and markedly reduced ERG signals. Genetic testing identifies the specific subtype, informs prognosis, and determines eligibility for gene-specific therapies.

1 program found for Leber Congenital Amaurosis (LCA)

Programs

1 program
Invitae Unlock™

Invitae Inherited Retinal Disorders Panel

This program offers U.S. clinicians access to comprehensive genetic testing for patients with suspected inherited retinal diseases, including RP, CRD, LCA, Stargardt disease, and other IRDs. Testing is also appropriate for asymptomatic individuals with a family history of IRD or a known pathogenic variant in a relevant gene, supporting diagnosis, risk assessment, and patient management.

Ophthalmology
ViewOrder
Performing labInvitae | Labcorp